» Articles » PMID: 20028947

Detailed Investigation of the Role of Common and Low-frequency WFS1 Variants in Type 2 Diabetes Risk

Abstract

Objective: Wolfram syndrome 1 (WFS1) single nucleotide polymorphisms (SNPs) are associated with risk of type 2 diabetes. In this study we aimed to refine this association and investigate the role of low-frequency WFS1 variants in type 2 diabetes risk.

Research Design And Methods: For fine-mapping, we sequenced WFS1 exons, splice junctions, and conserved noncoding sequences in samples from 24 type 2 diabetic case and 68 control subjects, selected tagging SNPs, and genotyped these in 959 U.K. type 2 diabetic case and 1,386 control subjects. The same genomic regions were sequenced in samples from 1,235 type 2 diabetic case and 1,668 control subjects to compare the frequency of rarer variants between case and control subjects.

Results: Of 31 tagging SNPs, the strongest associated was the previously untested 3' untranslated region rs1046320 (P = 0.008); odds ratio 0.84 and P = 6.59 x 10(-7) on further replication in 3,753 case and 4,198 control subjects. High correlation between rs1046320 and the original strongest SNP (rs10010131) (r2 = 0.92) meant that we could not differentiate between their effects in our samples. There was no difference in the cumulative frequency of 82 rare (minor allele frequency [MAF] <0.01) nonsynonymous variants between type 2 diabetic case and control subjects (P = 0.79). Two intermediate frequency (MAF 0.01-0.05) nonsynonymous changes also showed no statistical association with type 2 diabetes.

Conclusions: We identified six highly correlated SNPs that show strong and comparable associations with risk of type 2 diabetes, but further refinement of these associations will require large sample sizes (>100,000) or studies in ethnically diverse populations. Low frequency variants in WFS1 are unlikely to have a large impact on type 2 diabetes risk in white U.K. populations, highlighting the complexities of undertaking association studies with low-frequency variants identified by resequencing.

Citing Articles

The WFS1-ZnT3-Zn Axis Regulates the Vicious Cycle of Obesity and Depression.

Gong M, Fang Y, Yang K, Yuan F, Hu R, Su Y Adv Sci (Weinh). 2024; 11(41):e2403405.

PMID: 39258564 PMC: 11538679. DOI: 10.1002/advs.202403405.


The miR-668 binding site variant rs1046322 on is associated with obesity in Southeast Asians.

Hammad M, Abu-Farha M, Hebbar P, Anoop E, Chandy B, Melhem M Front Endocrinol (Lausanne). 2023; 14:1185956.

PMID: 37859980 PMC: 10583568. DOI: 10.3389/fendo.2023.1185956.


Evaluation of Type 2 Diabetes Risk Variants (Alleles) in the Pashtun Ethnic Population of Pakistan.

Jan A, Saeed M, Zakiullah , Akbar R, Khan H J ASEAN Fed Endocr Soc. 2023; 38(1):48-54.

PMID: 37234924 PMC: 10207872. DOI: 10.15605/jafes.037.S3.


, , , and Gene Polymorphisms Are Not Significant Risk Factors for Gestational Diabetes in the Polish Population.

Ustianowski P, Malinowski D, Safranow K, Dziedziejko V, Tarnowski M, Pawlik A J Pers Med. 2022; 12(2).

PMID: 35207731 PMC: 8878167. DOI: 10.3390/jpm12020243.


SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.

Chhichholiya Y, Suryan A, Suman P, Munshi A, Singh S Front Genet. 2021; 12:793523.

PMID: 34925466 PMC: 8673831. DOI: 10.3389/fgene.2021.793523.


References
1.
Sandhu M, Weedon M, Fawcett K, Wasson J, Debenham S, Daly A . Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007; 39(8):951-3. PMC: 2672152. DOI: 10.1038/ng2067. View

2.
Knight B, Shields B, Hattersley A . The Exeter Family Study of Childhood Health (EFSOCH): study protocol and methodology. Paediatr Perinat Epidemiol. 2006; 20(2):172-9. DOI: 10.1111/j.1365-3016.2006.00701.x. View

3.
Lauritzen T, Griffin S, Borch-Johnsen K, Wareham N, Wolffenbuttel B, Rutten G . The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord. 2000; 24 Suppl 3:S6-11. DOI: 10.1038/sj.ijo.0801420. View

4.
Takei D, Ishihara H, Yamaguchi S, Yamada T, Tamura A, Katagiri H . WFS1 protein modulates the free Ca(2+) concentration in the endoplasmic reticulum. FEBS Lett. 2006; 580(24):5635-40. DOI: 10.1016/j.febslet.2006.09.007. View

5.
Wareham N, Hennings S, Byrne C, Hales C, Prentice A, Day N . A quantitative analysis of the relationship between habitual energy expenditure, fitness and the metabolic cardiovascular syndrome. Br J Nutr. 1999; 80(3):235-41. DOI: 10.1017/s0007114598001287. View